Menu
With specialized and modified nucleosides, and innovative building blocks that drive breakthrough treatments, we’re committed to shaping the future of nucleic acid therapies
and drug development.
Founder, President & CEO
Sapala Organics
Chief Executive Officer
Suven Pharma
We offer a comprehensive range of specialized nucleic acid building blocks, heterocyclic compounds, drug delivery compounds, and Drug development.
Tailored solutions for Oligo Nucleotide synthesis using the modified phosphoramidites that are synthesised using deep expertise in Nucleic Acid Chemistry
Tailored solutions for drug development and delivery, with deep expertise in developing oligo-based therapies that target diseases at the genetic level.
State-of-the art analytical facility with wide array of Orthogonal analytical techniques for serving the customers from early R&D to Pharma innovators.
With 100+ years of leadership experience across nucleic acid chemistry, Sapala Organics has built a unique position in the Nucleic Acids market. Our extensive portfolio and cutting-edge technologies empower our clients to develop next-gen oligonucleotide drugs and therapies, including NCE (New Chemical Entity) programs using our expertise in Nucleic acid Building Blocks. Our comprehensive R&D capabilities, combined with manufacturing excellence, make us a trusted partner across the oligonucleotide value chain.
As a leading CRO and CDMO in nucleic acid space, Sapala Organics is committed to driving innovation and delivering breakthrough solutions for its clients. Our team’s unparalleled experience, combined with our state-of-the-art facilities, ensures that we are ready to meet the growing demand for next-gen therapies. Whether you are looking for a development partner or specialized manufacturing, we are here to collaborate with you.
